Literature DB >> 20084442

Primary Sjogren's syndrome with anticentromere antibodies--a clinically distinct subset.

Dhiraj Gulati1, Irving Kushner, Elizabeth File, Marina Magrey.   

Abstract

Primary Sjogren's syndrome (pSS) is a chronic autoimmune disorder of the exocrine glands. The diagnosis is largely based on keratoconjunctivitis sicca and xerostomia in the presence of anti-SS-A and/or SS-B antibodies. Anticentromere antibodies (ACA) have occasionally been reported in patients with pSS. We describe two patients with pSS associated with ACA, initially diagnosed as limited systemic sclerosis. Symptoms at the time of initial presentation were dry eyes and mouth, arthralgias, and Raynaud's phenomenon. Both patients developed small vessel cutaneous vasculitis, parotid enlargement, low C4 complement levels, positive rheumatoid factor, and lymphoma. These findings suggest that patients with pSS who have ACA may be a subgroup of patients at increased risk of extraglandular systemic manifestations and lymphoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20084442     DOI: 10.1007/s10067-009-1359-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  13 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

2.  Clinical and laboratory features of anticentromere antibody positive primary Sjögren's syndrome.

Authors:  K Katano; M Kawano; I Koni; S Sugai; Y Muro
Journal:  J Rheumatol       Date:  2001-10       Impact factor: 4.666

3.  Prevalence of anticentromere F protein autoantibodies in 347 patients with non-Hodgkin's lymphoma.

Authors:  Celine Bencimon; Gilles Salles; Annick Moreira; Stephanie Guyomard; Bertrand Coiffier; Jacques Bienvenu; Nicole Fabien
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

4.  Sjögren's syndrome with anticentromere antibodies.

Authors:  P Caramaschi; D Biasi; A Carletto; T Manzo; M Randon; S Zeminian; L M Bambara
Journal:  Rev Rhum Engl Ed       Date:  1997-12

5.  Anti-CENP-H antibodies in patients with Sjogren's syndrome.

Authors:  Tsai-Ching Hsu; Chih-Hsien Chang; Ming-Cheng Lin; Song-Tao Liu; Tim J Yen; Gregory J Tsay
Journal:  Rheumatol Int       Date:  2005-02-08       Impact factor: 2.631

6.  Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases.

Authors:  Manuel Ramos-Casals; Norma Nardi; Pilar Brito-Zerón; Sira Aguiló; Victor Gil; German Delgado; Albert Bové; Josep Font
Journal:  Semin Arthritis Rheum       Date:  2006-04       Impact factor: 5.532

Review 7.  Sjögren's syndrome.

Authors:  Robert I Fox
Journal:  Lancet       Date:  2005 Jul 23-29       Impact factor: 79.321

Review 8.  Sjögren's syndrome--study of autoantigens and autoantibodies.

Authors:  John G Routsias; Athanasios G Tzioufas
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

9.  Patients with anticentromere antibodies, clinical features, diagnoses and evolution.

Authors:  P G Vlachoyiannopoulos; A A Drosos; A Wiik; H M Moutsopoulos
Journal:  Br J Rheumatol       Date:  1993-04

Review 10.  Mortality in Sjögren's syndrome.

Authors:  M Voulgarelis; A G Tzioufas; H M Moutsopoulos
Journal:  Clin Exp Rheumatol       Date:  2008 Sep-Oct       Impact factor: 4.473

View more
  4 in total

Review 1.  Vasculitis in Sjögren's Syndrome.

Authors:  R Hal Scofield
Journal:  Curr Rheumatol Rep       Date:  2011-12       Impact factor: 4.592

2.  Serologic features of primary Sjögren's syndrome: clinical and prognostic correlation.

Authors:  Mario García-Carrasco; Claudia Mendoza-Pinto; César Jiménez-Hernández; Mario Jiménez-Hernández; Arnulfo Nava-Zavala; Carlos Riebeling
Journal:  Int J Clin Rheumtol       Date:  2012-12

3.  Anticentromere antibody positive Sjögren's Syndrome: a retrospective descriptive analysis.

Authors:  Vasiliki-Kalliopi K Bournia; Konstantina D Diamanti; Panayiotis G Vlachoyiannopoulos; Haralampos M Moutsopoulos
Journal:  Arthritis Res Ther       Date:  2010-03-13       Impact factor: 5.156

4.  Predicting the risk for lymphoma development in Sjogren syndrome: An easy tool for clinical use.

Authors:  Sofia Fragkioudaki; Clio P Mavragani; Haralampos M Moutsopoulos
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.